sulbactam has been researched along with Hemolysis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, B; Guo, G; Li, J; Wu, Y; Xiong, F; Yang, Y | 1 |
| Büyükokuroğlu, ME; Ciftçi, M; Küfrevioğlu, OI | 1 |
2 other study(ies) available for sulbactam and Hemolysis
| Article | Year |
|---|---|
Case Report: First Case of Cefotaxime-Sulbactam-Induced Acute Intravascular Hemolysis in a Newborn With ABO Blood Type Incompatibility by the Mechanism of Non-Immunologic Protein Adsorption.
Topics: ABO Blood-Group System; Acute Disease; Adsorption; Anemia, Hemolytic; Antigen-Antibody Reactions; Blood Group Incompatibility; Cefotaxime; Complement Activation; Coombs Test; Erythroblastosis, Fetal; Erythrocyte Membrane; Fatal Outcome; Female; Hemolysis; Humans; Immunoglobulin G; Infant, Newborn; Isoantibodies; Male; Maternal-Fetal Exchange; Pregnancy; Sulbactam; Young Adult | 2021 |
Effect of cefaperazone/sulbactam and ampicillin/sulbactam on the in vitro activity of human erythrocyte glucose-6-phosphate dehydrogenase.
Topics: Ammonium Sulfate; Ampicillin; Blood Proteins; Cefoperazone; Chromatography, Affinity; Drug Therapy, Combination; Electrophoresis, Polyacrylamide Gel; Erythrocytes; Glucosephosphate Dehydrogenase; Hemolysis; Humans; In Vitro Techniques; Kinetics; Sulbactam | 2001 |